Variant report
Variant | esv33163 |
---|---|
Chromosome Location | chr2:56199782-56203845 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-EFEMP1-1 | chr2:56202902-56203042 | NONHSAT070812 |
2 | lnc-EFEMP1-1 | chr2:56200943-56202732 | NONHSAT070812 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187362388 | chr2:56199802-56199803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs72813862 | chr2:56199810-56199811 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs112866921 | chr2:56199819-56199820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543384412 | chr2:56199839-56199840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532356278 | chr2:56199887-56199888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552549604 | chr2:56199920-56199921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs571281534 | chr2:56199941-56199942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144026416 | chr2:56199947-56199948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs146449781 | chr2:56200048-56200049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548776356 | chr2:56200054-56200055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568703397 | chr2:56200075-56200076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140845813 | chr2:56200076-56200077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532054150 | chr2:56200094-56200095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190609889 | chr2:56200135-56200136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115464335 | chr2:56200145-56200146 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570527443 | chr2:56200146-56200147 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552112982 | chr2:56200166-56200167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539031006 | chr2:56200173-56200174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552957013 | chr2:56200181-56200182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573034956 | chr2:56200189-56200190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs4453721 | chr2:56200190-56200191 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs555133234 | chr2:56200265-56200266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150087732 | chr2:56200340-56200341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544006536 | chr2:56200361-56200362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4635565 | chr2:56200365-56200366 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs544341180 | chr2:56200378-56200379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4589800 | chr2:56200399-56200400 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs181762450 | chr2:56200475-56200476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559724908 | chr2:56200487-56200488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528779509 | chr2:56200495-56200496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540959210 | chr2:56200549-56200550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12472832 | chr2:56200573-56200574 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs562260487 | chr2:56200624-56200625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531078963 | chr2:56200682-56200683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10192259 | chr2:56200747-56200748 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs551036987 | chr2:56200801-56200802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532318412 | chr2:56200870-56200871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76059728 | chr2:56200923-56200924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs62164513 | chr2:56200941-56200942 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs186093815 | chr2:56200962-56200963 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs530640770 | chr2:56200975-56200976 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs566503407 | chr2:56200990-56200991 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs190467389 | chr2:56201024-56201025 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs550395870 | chr2:56201105-56201106 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs537330886 | chr2:56201125-56201126 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs555196537 | chr2:56201134-56201135 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs568821344 | chr2:56201142-56201143 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs138646108 | chr2:56201180-56201181 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs182724114 | chr2:56201245-56201246 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs557952730 | chr2:56201247-56201248 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56193400-56202400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr2:56194000-56216200 | Weak transcription | Pancreas | Pancrea |
3 | chr2:56195800-56208600 | Weak transcription | HUVEC | blood vessel |
4 | chr2:56198200-56199800 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr2:56201400-56202200 | Enhancers | Stomach Smooth Muscle | stomach |
6 | chr2:56202200-56203000 | Weak transcription | Stomach Smooth Muscle | stomach |
7 | chr2:56202200-56203600 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr2:56202400-56202600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr2:56202400-56203000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr2:56202600-56202800 | Enhancers | HSMM | muscle |
11 | chr2:56202600-56203000 | Active TSS | GM12878-XiMat | blood |
12 | chr2:56203000-56203200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr2:56203000-56204400 | Enhancers | Stomach Smooth Muscle | stomach |
14 | chr2:56203200-56203400 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
15 | chr2:56203200-56204400 | Enhancers | Fetal Stomach | stomach |
16 | chr2:56203400-56203800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr2:56203400-56204200 | Enhancers | Colon Smooth Muscle | Colon |
18 | chr2:56203600-56204400 | Enhancers | Fetal Muscle Leg | muscle |
19 | chr2:56203800-56204000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |